Use of lepidylins in the treatment of nervous system cancer

PL250574B1Active Publication Date: 2026-11-16UNIWERSYTET MEDYCZNY W LUBLINIE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PL2023447378
Authority / Receiving Office
PL · PL
Patent Type
Patents
Current Assignee / Owner
Filing Date
2023-12-29
Publication Date
2026-11-16
Estimated Expiration
2043-12-29

Smart Images

  • Figure 00000006_0000
    Figure 00000006_0000
  • Figure 00000006_0001
    Figure 00000006_0001
  • Figure 00000007_0000
    Figure 00000007_0000
Patent Text Reader

Abstract

The purpose of the invention is to use lepidyllins B, C, and D for anticancer activity. The invention provides lepidyllins B, C, and D with molecular formulas of C20H23ClN2, C20H23ClN2O, and C21H25ClN2O, respectively, as imidazole alkaloid compounds for use in the treatment of nervous system cancer, preferably neuroblastoma. The invention provides the opportunity to utilize the anticancer activity of lepidyllins B, C, and D and use them as potential drugs or pharmaceutical ingredients in the pharmaceutical industry for the treatment of patients with nervous system cancer, particularly neuroblastoma.
Need to check novelty before this filing date? Find Prior Art